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Introduction: The clinical manifestations of sickle cell disease are related to the polymer-
ization of hemoglobin S. The chronic hemolysis caused by this condition often causes the
formation of gallstones that can migrate and block the common bile duct leading to acute
abdomen.
Objective: This study aimed to evaluate the proﬁle of patients with sickle cell disease and
cholelithiasis.
Methods: Patients with sickle cell disease were separated into groups according to the pres-
ence or absence of cholelithiasis. Socioepidemiological and clinical characteristics, such
as  gender, age, use of hydroxyurea and the presence of other hemoglobinopathies were
researched in the medical records of patients.
Results: A hundred and seven patients with sickle cell anemia were treated at the institution.
Of  these, 27 (25.2%) had cholelithiasis. The presence of cholelithiasis was higher in the 11–29
age  group than in younger than 11 years and over 29 years. No association was found for
the presence of cholelithiasis with gender, use of hydroxyurea or type of hemoglobinopathy
(hemoglobin SS, hemoglobin SC or sickle beta-thalassemia). Sixteen of the patients had to
be  submitted to cholecystectomy with 14 of the surgeries being performed by laparoscopy.
Complications were observed in three patients and one patient died for reasons unrelated
to  the surgery.
Conclusion: A quarter of patients with sickle cell disease had gallstones, more  commonly
in  the 11- to 29-year age range. Patients should be monitored from childhood to prevent
cholelithiasis with preoperative, intra-operative and postoperative care being crucial to
reduce the risk of complications in these patients.Please cite this article in press as: Martins RA, et al. Cholelithiasis and its 
Hematol Hemoter. 2016. http://dx.doi.org/10.1016/j.bjhh.2016.09.009
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Introduction
Sickle cell anemia is caused by a mutation in chromosome 11
that results in the replacement of glutamic acid with valine
at position 6 of the N-terminus of the globin chain. The clini-
cal manifestations of sickle cell disease are directly associated
with conformation changes in hemoglobin (Hb). In deoxygen-
ation events (hypoxia, dehydration, stress, low temperature,
acidosis, infection), because of the sickle shape of the red
blood cells (hence the name), Hb S becomes relatively insolu-
ble and aggregates into long polymers.1–4
Approximately 3500 people are estimated to be born with
sickle cell disease in Brazil every year, with an estimated
25,000–30,000 people having sickle cell anemia and at least
7,200,000 people carrying the sickle cell trait. The prevalence
of carriers of sickle cell trait ranges from 2% in the general
population to 6–12% in African descents.5
As the cells are abnormal, they have a shorter life than
normal red blood cells. Chronic hemolysis leads to continu-
ous production of bilirubin, which is conjugated in the liver
and excreted in the feces as urobilinogen; in large quantities,
it may form calcium bilirubinate gallstones. Cholelithiasis can
be detected even in under ﬁve-year-old children, but it is more
common in adolescents and adults with sickle cell anemia.
Gallstone migration can block the common bile duct lead-
ing to acute abdomen. Because of the potential complications
and severity of this condition, early diagnosis is of paramount
importance. Diagnostic imaging methods play a major role
when managing patients with sickle cell anemia, particularly
when evaluating complications. Early diagnosis and appropri-
ate treatment increase survival and improve the quality of life
of patients with sickle cell anemia.6–8
This study aimed to evaluate the proﬁle of patients with
sickle cell disease and cholelithiasis, the incidence of cases at
the Fundac¸ão Hemominas in Uberaba (FHU) and the Hospi-
tal das Clínicas of Universidade Federal do Triângulo Mineiro
(HC/UFTM) and the importance of early diagnosis for proper
treatment.
Methods
This is a retrospective descriptive study. A computerized
database was used to analyze patients with sickle cell dis-
ease referred to the FHU and to the HC/UFTM from 1995 to
2014. Diagnosis of cholelithiasis was performed by abdomi-
nal ultrasound and two groups of patients were formed: with
and without cholelithiasis. The following absolute and rela-
tive data regarding some socioepidemiological characteristics
were collected: gender (male, female), age (younger than 10
years, between 10 and 29 years, and older than 29 years), type
of hemoglobinopathy (Hb SS, Hb S/beta-thal, and Hb SC) and
use of hydroxyurea. The classiﬁcation of the hemoglobinopa-
thy was performed by electrophoresis on cellulose acetate at
alkaline pH.
The data was ﬁrst submitted to an analysis of absolute fre-Please cite this article in press as: Martins RA, et al. Cholelithiasis and its 
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quencies and percentages, and were organized in tables. An
Odds Ratio was calculated in order to study the association
between the characteristics of interest. The level of signiﬁ-
cance for all tests was set at 5%, and the data were analyzed 0 1 6;x  x x(x x):xxx–xxx
using the statistical software InStat 3.0 (GraphPad Software
Inc, La Jolla, CA, USA).
Results
One hundred and seven patients with sickle cell disease were
followed up in the Hematology/Hemotherapy Services of the
HC/UFTM and FHU during the study period. Twenty seven
(25.2%) of the patients had cholelithiasis.
A mean prevalence of 25.2% was observed for the diagnoses
of cholelithiasis. Of the 27 cases, 17 were investigated because
of clinical symptoms, whereas ten patients were diagnosed
during routine screening.
The percentage of cholelithiasis was higher in the 11–29
age group than in the age groups younger than 11 years and
over 29 years (p-value = 0.018); the vast majority of the patients
were diagnosed before 30 years of age, with an average age at
diagnosis of 16 years. Only four cases were diagnosed after 30
years old.
There were no signiﬁcant differences in frequency of
cholelithiasis between males and females (29.3% and 22.0%,
respectively; p-value = 0.400), between the group that used
hydroxyurea and the group that did not use this medicine
(32.4% and 21.4%, respectively; p-value = 0.215) and between
Hb SS, Hb S/beta-thal and Hb SC groups (28.4%, 25.0% and 7.1%,
respectively, p-value >0.05; Table 1). All Hb S/beta-thal patients
were Hb S/beta0.
Sixteen patients (59%) underwent cholecystectomy, four-
teen patients underwent laparoscopic surgery, and two  cases
underwent open surgery. Although laparoscopy had been
started in one of these two cases, laparotomy with emergency
splenectomy was performed with satisfactory results due to
excessive bleeding. Laparoscopy equipment was not available
at the time of the procedure of the other patient.
Three cases (18.7%) of the 16 operated patients developed
postoperative complications. One case required emergency
splenectomy due to bleeding, and another patient was a chole-
docholithiasis carrier submitted to endoscopic retrograde
cholangiopancreatography progressing to acute pancreatitis.
The patient was treated with a good response and then vide-
olaparoscopic cholecystectomy was performed without major
complications. One patient progressed to death 30 days after
surgery due to splenic sequestration.
Discussion
Cholelithiasis was signiﬁcantly more  prevalent in the 11–29
age group. These results suggest that this group should be
made aware of the risk of gallstones, related symptoms, pos-
sible complications, and the need for regular follow-ups with
routine preventive screenings. However, it should be high-
lighted that despite having found a higher occurrence in this
group, the screening of lithiasis secondary to chronic hemol-
ysis should be provided to all patients with sickle cell disease
regardless of their proﬁle in accordance with the Brazilian
9complications in sickle cell disease in a university hospital. Rev Bras
Handbook of Acute Events in Sickle Cell Disease.
A study conducted at the Universidade de Campinas found
a higher incidence of cholelithiasis in patients with sickle cell
disease (45%), as well as predominance of younger patients
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Table 1 – Distribution of patients with and without cholelithiasis regarding gender, age, use of hydroxyurea, and type of
hemoglobinopathy in the Hematology and Hemotherapy Service of the Universidade Federal do Triângulo Mineiro
(UFTM).
Patients
Total Without cholelithiasis Cholelithiasis
(107) (80) (27)
Epidemiological characteristic n n % n % OR 95% CI p-Value
Female 59  46 77.97 13 22.03 – – –
Male 48 34 70.83 14 29.17 0.69 (0.3–1.6) 0.400
<10 years 23 22 95.65 1 4.35 – – –
11–29 years 62 40 64.52 22 35.48 12.10 (1.5–95.9) 0.018a
≥30 years 22 18 81.82 4 18.18 4.90 (0.5–47.7) 0.172
Used hydroxyurea 37 25 67.56 12 32.43 – – –
Did not use hydroxyurea 70 55 78.57 15 21.42 1.76 (0.7–4.3) 0.215
Hb SS 81 58 71.60 23 28.40 2.4 (0.5–11.5) 0.280
Hb S/beta thalassemia 12 9 75.00 3 25.00 2.0 (0.3–14.6) 0.492
Hb SC 14 13 92.86 1 7.14 – – –
OR: Odds Ratio; 95% CI: 95% conﬁdence interval.
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<15 years). Sixty-three percent were Hb SS, with a statisti-
ally signiﬁcant predominance. Nonetheless, this study was
erformed only in children and adolescents and this may
ave contributed to the differing results. It is also important
o note that sickle cell disease has great variations in clin-
cal presentation, natural history and severity of hemolysis.
ome populations may have a lower frequency of cholelithi-
sis because of haplotype variations, environmental factors,
nd different clinical managements.6
The use of hydroxyurea was not associated with gallstones.
his contradicted our expectations as increased levels of fetal
emoglobin caused by this medication promote a decrease
n hemolysis of patients and it was expected that this would
ecrease the formation of gallstones. However, the ﬁndings
re not conclusive on this point because the study has the limi-
ation of not having been able to check the patients’ adherence
o the use of hydroxyurea. It was also not possible to identify
hether patients had already had gallstones before the use of
his medicine.
This study observed sixteen cases of symptomatic
holelithasis subjected to laparoscopy. The incidence of
rocedure-related complications was minimal and the
ast majority of patients progressed satisfactorily after
urgery.7,8 The surgical approaches used are laparotomy and
aparoscopy, with most authors considering the latter safer for
atients, with less complications related to surgery, shorter
perative time and faster postoperative recovery, as well as
 shorter hospital stay.10–14 However, a study published in
he International Journal of Surgery in 2009 found a positive
elationship between acute chest syndrome and laparoscopic
urgery. The study stated that the pneumoperitoneum and
espiratory acidosis secondary to the procedure are pre-
ictors of the syndrome and that, in order to minimizePlease cite this article in press as: Martins RA, et al. Cholelithiasis and its 
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he risk, surgery should be performed by an experienced
eam with less intrabdominal pressure and shorter operative
ime.8Elective removal of asymptomatic gallstones, diagnosed by
chance, is a controversial matter.7,8 Most experts, similar to in
the hematology service at UFTM, do not recommend surgery
before symptoms appear. There is evidence that this proﬁle
can be clinically managed for long periods,8,14 so the medical
team usually prescribe antispasmodic agents for minor pain
and recommend preventative measures such as a low-fat diet
for these patients.
Episodes of acute cholecystitis ought to be treated conser-
vatively with antibiotics, analgesia, and general care until the
crisis is over. Cholecystectomy should then be performed.7,8
Recently, the National Heart, Lung, and Blood Institute of
the United States recommended, from evidence-based man-
agement of sickle cell disease, that asymptomatic gallstones
should be treated with watchful waiting in children and
adults. In those who develop symptoms speciﬁc to gallstones,
cholecystectomy should be performed with the laparo-
scopic approach being preferred if surgically feasible and
available.15
Walker et al. observed a large number of asymp-
tomatic patients over 25 years of follow-up, and suggested
that research and surgery be indicated only for symp-
tomatic patients.16 However, cholecystectomy in asymp-
tomatic patients with sickle cell disease prevents the risk
of gallstone crises in this patient group. Authors advocat-
ing prophylactic cholecystectomy claim that this procedure
reduces the risk of complications such as acute chest syn-
drome, painful vaso-occlusive crises, and hepatic and splenic
sequestration associated with cholecystitis crises in sickle
cell patients. The authors also note that cholecystectomy
in gallstone patients allows the exclusion of this differen-
tial diagnosis in individuals with recurrent abdominal pain,
thus facilitating the diagnosis of abdominal vaso-occlusive cri-complications in sickle cell disease in a university hospital. Rev Bras
sis, which is quite frequent and has similar symptoms.10,16
Another argument against the indication of cholecistectomy
in the absence of symptoms would be the fact that surgery
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exposes patients to several factors that precipitate the sick-
ling of red blood cells, thus facilitating the onset of a severe
hemolytic crisis.7
Patients with sickle cell disease who are to be submit-
ted to anesthetic and surgical procedures require speciﬁc
care. Conditions associated with these procedures, such
as hypoxia, acidosis, hypothermia, infection, hematologic
instability and hypovolemia may have particularly serious
consequences for these patients. Therefore, in order to min-
imize the risk of these complications, it is recommended
that a multidisciplinary preoperative evaluation be per-
formed, as well as special attention be given to hydration
and oxygenation, and less invasive surgical procedures be
chosen, for example, laparoscopic surgery as well as spe-
cial postoperative care. Even though patients with sickle
cell disease are cared for, morbidity rates are as high
as 25%.7,8,10
The major postoperative complications described are as
follows: atelectasis, pneumonitis, pulmonary infarction and
infections.7,11–13,17,18 Three of the cases (18%) in this study
developed complications. The ﬁrst case was due to organ
damage during the procedure that required laparotomy and
emergency splenectomy with the patient having a good
evolution. In another case, the patient developed acute
pancreatitis after endoscopic retrograde cholangiopancre-
atography, but progressed well and subsequently underwent
laparoscopic cholecystectomy. Finally, in the third case, the
patient developed splenic sequestration 30 days after the pro-
cedure, was unresponsive to clinical measures, and evolved
to death. As the incident occurred days after the surgi-
cal process, we  discarded the association of death with
cholecistectomy.
In patients with pain in the right upper abdominal quad-
rant it is important to perform differential diagnoses of viral
hepatitis, vaso-occlusive crisis of the liver, common bile duct
obstruction, or drug-induced hepatotoxicity. Assessments of
the liver and gallbladder must be periodically made by labo-
ratory and imaging exams (radiography and ultrasound), and
the patient must be referred to specialized services.14
Conclusion
This study showed that a prevalence of 25.2% of gallstones
was observed in patients with sickle cell disease and 11- to
29-year-old patients have a higher incidence of gallstones.
So, patients with sickle cell disease should be monitored in
specialized centers on a regular basis by undergoing regu-
lar screening tests and by preventing this complication of
chronic hemolysis. Nonetheless, early diagnosis, and preop-
erative, intra-operative and postoperative care are mandatory
for a good progression of sickle cell disease and for less risk of
complications.Please cite this article in press as: Martins RA, et al. Cholelithiasis and its 
Hematol Hemoter. 2016. http://dx.doi.org/10.1016/j.bjhh.2016.09.009
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